Multiple myeloma (MM) remains incurable despite the current approaches used in initial therapy, including more effective induction therapy, one or more autologous stem-cell transplants, and consolidation/maintenance strategies.
Abhishek Singla, MBBS
Advertisement
Articles by Abhishek Singla, MBBS
Advertisement
Latest Updated Articles
- Current Advances in Non–Proteasome Inhibitor–Based Approaches to the Treatment of Relapsed/Refractory Multiple Myeloma
Published: November 15th 2011 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
FDA Slams REGENXBIO's MPS II Gene Therapy RGX-121 With CRL
2
Around the Helix: Cell and Gene Therapy Company Updates – February 11, 2026
3
American College of Physicians Calls for An End of the Term 'Provider' in Policy Paper
4
Guess the Therapy Answer February 11, 2026
5